CNS & Neurological Disorders-Drug Targets

Article	Citations
Meet the Editorial Board Member	113
Meet the Regional Editor	75
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation	64
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus	61
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer's Disease	60
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation	38
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives	37
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment	36
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis	36
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single	34
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis	32
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease	31
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease	30
Breaking Barriers: Advanced Pharmacological Mediators for Neuropsychiatric Disorders	30
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies	29
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review	28
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota	28
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature	25
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches	25
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound	25
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders	24
Insights into the Diagnosis, Treatment, and Management of Prion Diseases	24
Microbiota-Gut-Brain Axis: A Novel Paradigm in the Neurobiology of Anxiety	23
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and Targeted Therapeutics	22
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia	20

Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health	20
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis	20
AI-Driven Biomarker Discovery in Motor-Related Neurodegenerative Diseases	20
Clozapine in a Young Female with Drug-Resistant Schizophrenia: A Case Report of Development of Serositis	19
Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?	19
Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1- Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways	18
Vasospasm in Pediatric Subarachnoid Hemorrhage	18
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease	18
Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders	18
An Overview of the Natural Neuroprotective Agents for the Management of Cognitive Impairment Induced by Scopolamine in Zebrafish (Danio rerio)	18
A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease	18
WITHDRAWN: Nigella Fixed Oil Mitigates Memory Impairment in a Rat-Aged Model of Cognitive Decline; A Pivotal Role of BDNF and CREB Signaling Pathways in the Hippocampus	18
Analysis of Concentrations of Monomethyl Fumarate in Patients with Multiple Sclerosis: Result from Routine Health Care	17
Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine	17
Black phosphorus in neurological disorders: Current therapeutic applications, mechanisms, and future prospects	17
High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Accelerates onset Time of Beneficial Treating Effects and Improves Clinical Symptoms of Depression	17
IL-33 is Required for Behavioral Deficits in a Murine Model of Systemic Lupus Erythematosus Through Regulation of Microglia Glycolysis	17
Solid Lipid Nanoparticle Mediated Intranasal Drug Delivery for Brain Targeting: A Comprehensive Review	17
Decoding the Gut-Brain Axis in Alzheimer's Disease: Emerging Perspectives	16
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models	16
Navigated Transcranial Magnetic Stimulation (nTMS) based Preoperative Planning for Brain Tumor Treatment	16
Impact of Structured Physical Exercise on Adolescent Depression: A Comprehensive Meta-Analysis of RCTs	15
Genetic Predisposition and Severity of Eating Disorders- A Review	15
Evolutionary Unmasking Resuscitative Therapeutics Potential of Centhaquin Citrate in Hypovolemic Shock	14
Obesity and Depression: Common Link and Possible Targets	14
Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status	14
Natural Products as Bioactive Agents in the Prevention of Dementia	14
Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review	14
Comparison of the Sedative Effect of Ketamine, Magnesium Sulfate, and Propofol in Patients Undergoing Upper Gastrointestinal Endoscopy: Double-Blinded Randomized Clinical Trial	14
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings	14
Acknowledgements to Reviewers	13
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease	13
Hematological Consequences of Valproic Acid in Pediatric Patients: A Systematic Review with a Mechanistic Approach	13
Bis-iodine-labeled Curcumin as a Potential CT Imaging Agent for β-amyloid Plaques in the Brain	13
Transcription Factor Pet-1/FEV as a Potential Therapeutic Target in Anxiety and Depressive Disorders	13
Targeting Blood-Brain Barrier Damage with Nanotechnology in the Fight Against Neurodegenerative Diseases	13
The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping Review	13
Effect of Dual-task Exercise on Cognition and Dual-task Cost in the Elderly with Mild Cognitive Impairment: A Randomized Pilot Study	13
Mechanism of Glioblastoma Treatment Targeting Growth Factors: IGF-I Case Using Gene, Immune, Phytochemicals, and Nanotechnologies	12
Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders	12
Effects of Hesperetin Early Intervention on Brain Neurons and Microglia in APPswe/PS1dE9 Mice	12
The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future Aspects	12
Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases	12
Emerging Treatments for Subarachnoid Hemorrhage	12
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?	12
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology	12
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review	12
The Effects and Regulatory Mechanism of Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi in Promoting Neurogenesis and Improving Memory Impairment Mediated by the BDNF-ERK-CREB Signa	12
Sweroside Modulates Oxidative Stress and Neuroplasticity-Related Gene Expression in Scopolamine-Treated Zebrafish	12
Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects	11

Valproate Exposure as an In vitro Model for Studying Morpho-Molecular Features of ASD: A Systematic Review	11
Lithium Chloride Rescues Dopaminergic Neurons in a Parkinson’s Disease Rat Model Challenged with Rotenone	11
Acknowledgements to Reviewers	11
Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders	11
Pharmacotherapy in SAH: Clinical Trial Lessons	11
WITHDRAWN: Neurological Studies Of Herbal Medicinal Plants For The Treatment Of Memory Impairment: A Review	11
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series	11
Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors	11
Lorcaserin: Worthy of Further Insights? Results from Recent Research	10
Neurological Manifestations Following Traumatic Brain Injury: Role of Behavioral, Neuroinflammation, Excitotoxicity, Nrf-2 and Nitric Oxide	10
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases	10
One-Trial Appetitive Learning Tasks for Drug Targeting	10
Insights into the Molecular Mechanisms of Neurodegenerative Diseases: Exploring Molecular Pathways and the Therapeutic Potential of Rivastigmine	10
Benzodiazepines and Sleep Architecture: A Systematic Review	10
Cannabidiol in Epilepsy: Restoring Locomotion and Seizure Control	10
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO	10
Rethinking Catatonia: New Insights from the Autism Spectrum	10
Focused Ultrasound-activated Extracellular Vesicles–nanoparticle Hybrids for Targeted Brain Drug Delivery: Engineering Strategies and Translational Outlook	10
Peripheral Vascular Disease is Associated with Impaired Activities of Daily Living in the Elderly with Dementia: A Prospective Study	9
The Peripheral Profile of the Chitinase 3-like-1 in Benign Multiple Sclerosis – A Single Centre’s Experience	9
Endophenotypes and Pathway Phenotypes in Neuro-psychiatry: Crossdisciplinary Implications for Diagnosis	9
Design and Molecular Docking Studies of N-Mannich Base Derivatives of Primaquine Bearing Isatin on the Targets involved in the Pathophysiology of Cerebral Malaria	9
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets	9
Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights	9
Neurotoxicity of Endogenous Neurotoxin Salsolinol in Parkinson's Disease	9
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease	9
Neuroprotection or Sex Bias: A Protective Response to Traumatic Brain Injury in the Females	9
Therapeutic Potential of Nutritional Modulators in Traumatic Brain Injury: A Systematic Review	9
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities	9
The Protective Role of L-carnitine on Psychosocial Stress-induced Changes in Gene Expression and Protein Levels of Matrix Metalloproteinases, Serum Corticosterone in a Rat Model	9
Nicotine Abuse and Neurodegeneration: Novel Pharmacogenetic Targets to Aid Quitting and Reduce the Risk of Dementia	9
Ameliorating Effects of Virgin Coconut Oil (VCO) on Nicotine Dependence and Quality of Life in Smokers	9
Role of Unani Polyherbal Formulations in the Treatment of Diseases with Special Reference to Neurodegenerative Disorders	9
Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm	9
Nanotechnological Advances in the Treatment of Epilepsy	9
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease	9
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders	9
Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment	9
Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Randomized Controlled Trial	9
Anaesthesia-induced Changes in Genomic Expression Leading to Neurodegeneration	8
Targeting Vascular Dementia: Pharmacological Mechanisms and Therapeutic Strategies	8
The Role of Ca2+ Permeable AMPA Receptors in Neurodegeneration, Neurotoxicity, and Neuroinflammation	8
Preface	8
Nicotine Dependence-Induced Withdrawal Syndrome: Mechanistic Insights and Therapeutic Implications	8
Valproic Acid and Celecoxib Enhance the Effect of Temozolomide on Glioblastoma Cells	8
Zederone Improves the Fecal Microbial Profile in Dementia Induced Rat Model: A First Report	8
The Role of the cGAS-STING Pathway in Central Nervous System Diseases	8
Protective Effects of Memantine Against Acute Stress-Induced Fear Memory and Synaptic Dysfunction via NMDA Receptor Antagonism	8
Meet the Editorial Board Member	7
Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs	7
Integrating Synthesis, Pharmacological Activity, and Molecular Modeling to Explore 1,2,4-Triazine Fused Thiazolidin-4-one Derivatives as GABAA Receptor Modulators	7
Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis	7
Parkinson’s Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen	7
Early Detection of Glioma: Investigating Inflammatory Markers (CRP), Kidney, and Liver Function	7
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity	7
Association between Frequency of Seizures and Number of Antiseizure Medications (ASM) in Patients with Epilepsy	7
How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age?	7
Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson’s Disease	7
An Overview of Acute Flaccid Myelitis	7
Bibliometric Analysis of Neutrophil Extracellular Traps in Stroke: Research Trends and Hotspots	7
Imbalance of Th1 and Th2 Cytokines and Stem Cell Therapy in Pathological Pain	7
Cyclodextrins-Phospholipids Complex Loaded Nanofibers for Improved Oral Bioavailability and Brain Targeting for Management of Stress and Anxiety	7
An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease	7
Abnormality of Voltage-Gated Sodium Channels in Disease Development of the Nervous System. A Review Article	7
Flow Diversion for the Management of Posterior Circulation’s Intracranial Aneurysms	7
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety	7
Acute Peripheral Facial Nerve Palsy in Children and Adolescents: Clinical Aspects and Treatment Modalities	7
Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders	7
Synergistic Roles of Neuropeptide S and Environmental Enrichment in Preclinical Huntington’s Disease Depression Models	7
The Possible Protective Effect of Taurine on Bisphenol Induced Structural Changes on the Cerebral Cortex of Rats: Histological and Immunohistochemical Study	6
Implication of HPA-axis Dysfunction in Depression: From Neurobiological Mechanisms to Future Treatment Strategies	6
A Systematic Review of Recent Advances in Drug Delivery to the Central Nervous System Through Prodrug Approach	6
Speech as a Biomarker for Depression	6
Hypoxia-inducible Factor-1α Pathway in Cerebral Ischemia: From Molecular Mechanisms to Therapeutic Targets	6
Metabolic Disorder Therapeutics and their Effects on Memory	6
Pre-clinical Aspects and Contemporary Treatments of Parkinson’s Disease	6
A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease	6
Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders	6
Acknowledgements to Reviewers	6
Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects	6

Dietary Xylitol Supplement Ameliorated AD-related Neuronal Injury by Regulating Glucose Metabolism Relevant Amino Acids in Mice	6
Dopamine Depletion in Parkinson’s Disease and Therapeutic Options	6
Preface	6
Role of Lipocalin-2 in N1/N2 Neutrophil Polarization After Stroke	6
Ferroptosis Targeting Offers a Therapeutic Strategy for Subarachnoid Hemorrhage	6
From Anesthetic to Neuroprotector: Multi-Omics Reveals Ketamine's Previously Unexplored Neuroprotective Role in Alzheimer's Disease	6
WITHDRAWN: Neuroprotective Effect of 3,3′-Diindolylmethane and ɑ-Naphthoflavone, Aryl Hydrocarbon Receptor Modulators, in an Experimental Model of Ischemic Stroke	6
Neuroinflammation, Autophagy, and Neurodegeneration: Mechanisms and Therapeutic Insights	6
Evaluation of Associated Genes with Traumatic Pain: A Systematic Review	6
Notopterygium incisum Root Extract (NRE) Alleviates Epileptiform Symptoms in PTZ-Induced Acute Seizure Mice	6
β-Amyloid Pathways in Alzheimer's Disease: Mechanisms and Therapeutic Targets	6
Meet the Editorial Board Member	6
Role of Imaging Genetics in Alzheimer’s Disease: A Systematic Review and Current Update	6
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms	5
Effect of Natural Plant Products on Alzheimer’s Disease	5
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier	5
Role of Vitamins in Neurodegenerative Diseases: A Review	5
Cell-Free DNA, a Noninvasive Biomarker for Prediction and Detection of Neurodegenerative Diseases, New Insights, and Perspectives	5
Immunotherapeutics for AD: A Work in Progress	5
Exploring LRRK2-dependent Mechanisms in Parkinson’s Disease Therapy	5
Sleep-Related Disorders in Parkinson's Disease: Mechanisms, Diagnosis, and Therapeutic Approaches	5
Hypothesis-Driven Insights and Clinical Trial Updates in Alzheimer’s Disease Pathogenesis	5
Nordihydroguaiaretic Acid Affects Undifferentiated and Differentiated Neuroblastoma Cells Differently through Mechanisms that Impact on Cell Viability	5
Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management	5
A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders	5
Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease	5
Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients	5
The Use of Benzodiazepines and Risk of Incident Type 2 Diabetes in the General Population with Insomnia	5
Pharmacological Breakthroughs with Extracellular Vesicles-Based Nanomedicine: A Targeted Strategy to Cross the Blood-Brain Barrier in Alzheimer’s Disease	5
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update	5
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease	5
Ablation of Shank1 Protects against 6-OHDA-induced Cytotoxicity via PRDX3-mediated Inhibition of ER Stress in SN4741 Cells	5
Comparison of Safety and Effectiveness between Levetiracetam and Phenytoin in the Treatment of Pediatric Status Epilepticus: A Meta- Analysis	5
Subarachnoid Hemorrhage	4
Pharmacology and Pharmacogenomics of Anti-Migraine Drugs	4
The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney Function	4
Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-loaded Solid Lipid Nanoparticles: Modulation of Cellular Signaling Pathways	4
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals	4
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches	4
Modeling of Parkinson's Disease in Different Models	4
Hesperetin Early Intervention Reduces Β-Amyloid Production in APP/PS1 Mice by Decreasing Beta and Gamma-Secretase Enzyme	4
The Effectiveness of Transcranial Magnetic Stimulation in Treating Apraxia	4
User-Centered Design of Neuroprosthetics: Advancements and Limitations	4
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease	4
Oxytocin Effect in Adult Patients with Autism: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials	4
Reciprocal Interaction of Pain and Brain: Plasticity-induced Pain, Pain-induced Plasticity, and Therapeutic Targets	4
Common microRNAs in Epilepsy and Migraine: Their Possibility as Candidates for Biomarkers and Therapeutic Targets during Comorbid Onset of Both Conditions	4
Meet the Frontier Section Editor	4
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease	4
Fluoride-induced Neurodevelopmental Toxicity- AMPK as a Possible Target	4
Immunotherapeutic Approaches for the Treatment of Neurodegenerative Diseases: Challenges and Outcomes	4
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease	4
Nutritional Support System (NSS) as a New Therapeutic Strategy for Cerebral Palsy	4
Phytotherapeutics against Alzheimer’s Disease: Mechanism, Molecular Targets and Challenges for Drug Development	4
Unraveling the Emerging Niche Role of Extracellular Vesicles (EVs) in Traumatic Brain Injury (TBI)	4
The Interplay between PKC and ELAV4 in the CNS: An Emerging Therapeutic Axis for Dementia Management	4
A Potential Strategy for Treating Parkinson's Disease Through Intranasal Nanoemulsions	4
The Participation of Ca2+ Channels in Epilepsy: A Bibliometric Analysis of the Scientific Literature in Latin America	4
Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation	4
Biotechnological Perspectives on GSK-3β and Hyperprolactinemia: Implications for the Progression of Alzheimer’s Disease	4
Dipsacoside B Exerts a Beneficial Effect on Brain Injury in the Ischemic Stroke Rat through Inhibition of Mitochondrial E3 Ubiquitin Ligase 1	4
Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation	4
Immune Cell Infiltration and Key Gene Identification in Alzheimer's Disease and Sleep Deprivation	3
Smartphone Addiction among Students and its Harmful Effects on Mental Health, Oxidative Stress, and Neurodegeneration towards Future Modulation of Anti-Addiction Therapies: A Comprehensive Survey base	3
Role of Autophagy and Mitophagy in Neurodegenerative Disorders	3
Mycotoxins and Amyotrophic Lateral Sclerosis: Food Exposure, Nutritional Implications and Dietary Solutions	3
Targeting Dopaminergic Pathways: Current and Emerging Dopamine Inhibitors in Neurological and Psychiatric Disorders	3
Meet the Editorial Board Member	3
Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease	3
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Regulate the Brain Tau Hyperphosphorylation at Multiple Sites Induced by Composited Aβ in Rats	3
In Silico and ADMET Studies of Spiro-Quinazoline Compounds as Acetylcholine Esterase Inhibitors Against Alzheimer’s Disease	3
Trends and Perspectives in the Rational Management of CNS Disorders	3
Meet the Co-Editor	3
Vitamin D and Neurological Health: Unraveling Risk Factors, Disease Progression, and Treatment Potential	3
Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review	3
Zebrafish (Danio rerio) as a Model for Neurodegenerative Disease Research: Mechanisms, Biomarkers, and Translational Promise	3
A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson’s Disease: An Updated Patent and Clinical Trials	3
Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia	3
Recent Updates on Lipid Landscapes in Neonatal and Adult Neurological Disorders: Advancing Mass Spectrometry and Lipidomics for Disease Insight: A Systematic Review	3
Electrolyte Imbalance and Neurologic Injury	3
Real-World Data Regarding Long-Term Administration of Natalizumab Derived from a Neurology Department along with Literature Review	3
Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam	3
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship	3
Meet the Associate Editorial Board Member	3
The Effects and Mechanism of Scutellaria baicalensis Georgi Stems and Leaves Flavonoids on Myelin Sheath Degeneration Induced by Composite Aβ in Rats	3
The Neuroprotective Role of BCG Vaccine in Movement Disorders: A Review	3
Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders: A Systematic Review	3
Meet the Editorial Board Member	3
Lifestyle Modulators of Neuroplasticity in Parkinson’s Disease: Evidence in Human Neuroimaging Studies	3
Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms	3
Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in	3
Preface	3
L-Ala-L-Gln Suppresses Hypoxic Phenotype and Fibrogenic Activity of Rat Perineurial Fibroblasts	3
Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?	3
Reconnoitering the Potential of the Pharmacogenomics Approach in the Management of Alzheimer's Disease: A Review	3